Streetbeat News

Revenues

AXON

Axon Enterprise reported a strong Q3 with revenues increasing by 31.7% year over year, driven by its Software & Sensors and TASER segments. The company also raised its outlook for 2024.

Portfolio Pulse from

November 08, 2024 | 4:45 pm

MQ

Levi & Korsinsky has initiated an investigation into Marqeta, Inc. for potential securities fraud, following the company's reduction in its Q4 revenue growth forecast.

Portfolio Pulse from

November 08, 2024 | 4:45 pm

NVS

REGN

The report on the Age-Related Macular Degeneration (AMD) Drugs Market forecasts trends and developments from 2024 to 2029, focusing on products like Lucentis, Eylea, and Vabysmo, and molecules such as Ranibizumab and Aflibercept.

Portfolio Pulse from

November 08, 2024 | 4:45 pm

TRIP

Tripadvisor (TRIP) is recommended as a Strong Buy due to Viator's growth, a strong balance sheet, and potential strategic acquisitions. Viator's Q3 2024 revenue exceeded Tripadvisor's legacy segment for the first time, indicating positive trends despite a disappointing quarter.

Portfolio Pulse from

November 08, 2024 | 4:45 pm

CCOI

Cogent Communications reported a narrower-than-expected loss for Q3, despite a year-over-year decline in revenues due to decreasing customer connections. However, the company saw healthy growth in wavelength sales.

Portfolio Pulse from

November 08, 2024 | 4:45 pm

HOG

Harley-Davidson's shares have declined by 3% following their Q3 earnings report, which exceeded expectations. However, the company has reduced its 2024 revenue guidance for the HDMC segment.

Portfolio Pulse from

November 08, 2024 | 4:45 pm

GOLD

Barrick Gold's Q3 earnings fell short of estimates despite an increase in sales year-over-year. The company benefited from higher average realized gold prices, but faced challenges with lower production and increased costs.

Portfolio Pulse from

November 08, 2024 | 4:45 pm

QCOM

The article discusses a promising artificial intelligence stock with growing revenue and profits, with expectations of continued success through 2025.

Portfolio Pulse from

November 08, 2024 | 4:45 pm

HUN

Huntsman Corporation's Q3 earnings exceeded expectations, but revenues fell short. The increase in Polyurethanes sales was driven by higher sales volumes, despite a decrease in MDI prices.

Portfolio Pulse from

November 08, 2024 | 4:45 pm

PACB

Pacific Biosciences (PACB) reported a decline in Q3 2024 revenues year-over-year, despite beating earnings expectations. Consumable and service revenues increased.

Portfolio Pulse from

November 08, 2024 | 4:30 pm